212Pb in targeted radionuclide therapy: a review
Abstract Background The selective delivery of α-emitting radionuclides is emerging as a highly effective form of cancer therapy. With a short range and high cytotoxicity, α-particles can selectively kill cancerous cells whilst minimising harm to surrounding healthy tissue. As the parent of the α-emi...
Saved in:
| Main Authors: | Jarred Michael Scaffidi-Muta, Andrew David Abell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-07-01
|
| Series: | EJNMMI Radiopharmacy and Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41181-025-00362-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
by: Solmaz Mojarad-Jabali, et al.
Published: (2025-01-01) -
Gamma camera imaging characteristics of 203/212Pb as a theragnostic pair for targeted alpha therapy: a feasibility study
by: David Kästner, et al.
Published: (2025-05-01) -
Antigen targeting and anti-tumor activity of a novel anti-CD146 212Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma
by: Kim Lindland, et al.
Published: (2024-10-01) -
Targeted alpha-particle therapy in neuroendocrine neoplasms: A systematic review
by: Thuan Koh, et al.
Published: (2021-10-01) -
Half-life measurements of 212Po with thorium-loaded liquid scintillator
by: P. Belli, et al.
Published: (2018-09-01)